Novel Flow Solutions in Urology and Vascular Disease
Our Products
Noninvasive Urethro-Cystometer(NUC): A device for differential diagnosis of Lower Urinary Tract Symptoms (LUTS) in the elderly male. Licensed to a medical device company and currently being marketed.
Revealing the Missing Physiologic Layer of Inflammation:
The Biofluid Inflammometer™ is a novel diagnostic platform designed to quantify whole blood viscosity across physiologic conditions and translate those measurements into clinically meaningful insight into systemic inflammation and microvascular function.
Inflammation is traditionally assessed through biochemical markers, yet these measurements provide limited insight into how inflammatory processes affect blood flow, tissue perfusion, and organ function in real time.
The Biofluid Inflammometer™ addresses this gap by measuring the flow properties of whole blood across physiologically relevant shear conditions, capturing a functional dimension of disease that is not reflected in standard laboratory testing.
Current diagnostics measure what is present in the blood. The Biofluid Inflammometer™ measures how the blood behaves.
Disclaimer: The medical devices described herein are limited by federal (U.S.) law to investigational use. They have not yet been approved for clinical diagnostic application.
About Us
BioFluid Technology is a development stage medical device company established in 2010. Based on technology and expertise from scientists at the University of Pennsylvania, BioFluid Technology is focused on the research and development of patented diagnostic devices that measure the physical properties and flow characteristics of biological fluids.
Contact Us
BioFluid Technology Inc.
337 Fishers Road
Bryn Mawr, PA 19010
(610) 527-4530
Preferred Contact:
reuben.kron@biofluidtechnology.com
References
Urological Cystometry
-
Noninvasive techniques for the measurement of isovolumetric bladder pressure. Blake C, Abrams P. J Urol. 2004 Jan;171(1):12-9.
-
Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 2: Noninvasive urodynamics and combination of measures. Belal M, Abrams P. J Urol. 2006 Jul;176(1):29-35.
-
Positioning invasive versus noninvasive urodynamics in the assessment of bladder outlet obstruction. Arnolds M, Oelke M. Curr Opin Urol. 2009 Jan;19(1):55-62.
-
Review of invasive urodynamics and progress towards non-invasive measurements in the assessment of bladder outlet obstruction. Griffiths CJ, Pickard RS. Indian J Urol. 2009 Jan;25(1):83-91.
-
Non-invasive urodynamics predicts outcome prior to surgery for prostatic obstruction. Losco G, Keedle L, King Q. BJU Int. 2013 Nov;112 Suppl 2:61-4.
Cardiovascular Viscometry
Viscometry and COVID-19
-
Maier, CL., Truong, AD., Auld, SC., Polly, DM., Tanksley, CL., Duncan, A. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia? Lancet. 2020, Jun 6;395(10239):1758-1759
-
Ahmed, S., Zimba, O., Gasparyan, AY. Thrombosis in Coronavirus Disease 2019 (COVID-19) through the prism of Virchow's triad Clin Rheumatol 2020, Sep;39(9):2529-2543.
(under development)
Specialty Areas
Urology
Hematology
Rheumatology
Laboratory Medicine
Internal Medicine
Primary Care
Infectious Disease
Cardiovascular Disorders